Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Cognitive Dysfunction and Dementia in Primary Sjögren's Syndrome.
Optical coherence tomography in the diagnosis and management of optic neuritis and multiple sclerosis.
Metabolomics in multiple sclerosis.
A Limited Form of Neuromyelitis Optica With a Lesion of the Fourth Nerve Nucleus.
Genetic associations of leukoaraiosis indicate pathophysiological mechanisms in white matter lesions etiology.
Normal Diffusion-Weighted MRI During the Acute Stage of Central Pontine Myelinolysis.
Preclinical Models of Multiple Sclerosis: Advantages and Limitations towards Better Therapies.
Crosstalk between endocannabinoid and immune systems: a potential dysregulation in depression?
Researchers Expand Focus on Progressive Forms Of Multiple Sclerosis: Efforts to Pinpoint the Beginning of Disease May Yield Clues to Treatment.
Multiple Sclerosis.
[Animal models of Charcot-Marie-Tooth disease and their relevance for understanding the disease in humans.]
MSRV envelope protein is a potent, endogenous and pathogenic agonist of human toll-like receptor 4: Relevance of GNbAC1 in multiple sclerosis treatment.
5-Aminoisoquinolin-1-one (5-AIQ), a Water-Soluble Inhibitor of the Poly¬(ADP Ribose)¬Polymerases (PARPs).
Novel pathogenic epitopes of myelin oligodendrocyte glycoprotein induce experimental autoimmune encephalomyelitis in C57BL/6 mice.
New Developments in Murine Imaging for Assessing Photoreceptor Degeneration In Vivo.
A comprehensive approach to the segmentation of multichannel three-dimensional MR brain images in multiple sclerosis.
Heat shock protein 70 (Hsp70) interacts with the Notch1 intracellular domain and contributes to the activity of Notch signaling in myelin-reactive CD4 T cells.
Correlation between Magnetic Resonance Imaging Findings and Pathological Observations in Tumefactive Multiple Sclerosis.
The Rao's Brief Repeatable Battery version B: normative values with age, education and gender corrections in an Italian population.
[There is evidence for the use of cannabinoids for symptomatic treatment of multiple sclerosis].
Atypical presentation of Charcot-Marie-Tooth disease 1A: A case report.
Poor Sleep in Multiple Sclerosis Correlates with Beck Depression Inventory Values, but Not with Polysomnographic Data.
The natural dual cyclooxygenase and 5-lipoxygenase inhibitor flavocoxid is protective in EAE through effects on Th1/Th17 differentiation and macrophage/microglia activation.
Anti-annexin antibodies, cholesterol levels and disability in multiple sclerosis.
Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS.
Pages
« first
‹ previous
…
668
669
670
671
672
673
674
675
676
…
next ›
last »